SCHEMBL6002998

SCHEMBL6002998

[CH2]c1oc2ccccc2c1Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
KDM4E B2RXH2 6/20 0.48
MAOA P21397 5/20 0.48
MAPT P10636 3/20 0.48
HPGD P15428 3/20 0.48
HSD17B10 Q99714 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP3A4 P08684 2/20 0.48
GLA P06280 1/20 0.48
PGAM1 P18669 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
NQO1 P15559 2/20 0.41
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA9 Q16790 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM5 P08912 1/20 0.39
CHRM1 P11229 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22960257 0.76 CHRM2 (0.53) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL2442045 0.76 KDM4E (0.46) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL31450995 0.73 AHR (0.45) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL4741002 0.73 SMN1; SMN2 (0.48) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL15442574 0.73 KDM4E (0.43) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL11389406 0.73 KDM4E (0.43) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL2675092 0.73 ALDH1A1 (0.43) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL22273765 0.73 KDM4E (0.47) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL31318453 0.73 CYP2C19 (0.46) ALDH1A1KDM4EMAOAMAPTHPGD
SCHEMBL3380593 0.73 CYP2C19 (0.46) ALDH1A1KDM4EMAOAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed